STOCK TITAN

GE HealthCare Technologies (GEHC) SEC Filings, Jul-Sep 2025

GEHC NASDAQ

GE HealthCare Technologies Inc. filings document formal disclosures for a medical technology and diagnostics company, including Form 8-K reports on results of operations and financial condition, material agreements, capital-structure matters, and governance changes. Recent current reports include earnings releases, a senior unsecured revolving credit facility, and board-related disclosures.

The company’s proxy materials describe annual-meeting matters, director elections, board committee assignments, executive compensation, equity awards, and shareholder voting procedures. GEHC filings also provide formal context for segment performance, liquidity arrangements, credit covenants, and governance matters tied to its healthcare technology, software, and pharmaceutical diagnostics businesses.

Rhea-AI Summary

GE HealthCare Technologies Inc. Chief Financial Officer James Saccaro reported two tax-withholding dispositions of common stock on September 1, 2025, when shares were withheld to cover taxes upon vesting of restricted stock units. In total, 3,238 shares were withheld at $73.73 per share. After these transactions, he directly holds 58,594 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.40%
Tags
insider
-
Rhea-AI Summary

GE HealthCare Technologies Inc. Director and President/CEO Peter J. Arduini reported two dispositions of common stock that occurred on 09/01/2025. The filings show 5,874 shares and 5,472 shares were disposed of at $73.73 per share, for a total of 11,346 shares removed via withholding to satisfy tax obligations tied to the vesting of restricted stock units.

After these transactions Mr. Arduini beneficially owned 173,354 shares on one reported line and 167,882 shares on the other, with all holdings reported as direct ownership. The form indicates the share withholding was used solely to meet tax withholding from RSU vesting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.40%
Tags
insider
-
Rhea-AI Summary

Kenneth R. Stacherski, an officer of GE HealthCare Technologies Inc. (GEHC), was awarded 10,217 restricted stock units (RSUs) on 08/15/2025. Each RSU converts to one share of GE HealthCare common stock at settlement. The award vests 50% on 08/15/2027 and 50% on 08/15/2028. Following the grant, the reporting person beneficially owns 41,888 shares. The Form 4 was signed by the company General Counsel as attorney-in-fact on 08/19/2025. No derivative transactions or cash purchase price were reported for this grant.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
insider
Rhea-AI Summary

Dodge & Cox reports beneficial ownership of 23,567,950 shares of GE HealthCare Technologies, representing 5.1% of the company's common stock. The filing shows sole voting power for 22,284,487 shares and sole dispositive power for 23,567,950 shares. The reporting person is identified as an investment adviser (IA), and the filing states that Dodge & Cox clients have the right to receive dividends and proceeds from these securities. The filer certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.82%
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.82%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
current report

FAQ

How many GE HealthCare Technologies (GEHC) SEC filings are available on StockTitan?

StockTitan tracks 107 SEC filings for GE HealthCare Technologies (GEHC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for GE HealthCare Technologies (GEHC)?

The most recent SEC filing for GE HealthCare Technologies (GEHC) was filed on November 18, 2026.